Literature DB >> 33507997

Choroidal congestion mouse model: Could it serve as a pachychoroid model?

Hidetaka Matsumoto1, Ryo Mukai1, Junki Hoshino1, Mai Oda2, Toshiyuki Matsuzaki3, Yasuki Ishizaki2, Koji Shibasaki4, Hideo Akiyama1.   

Abstract

Pachychoroid spectrum diseases have been described as a new clinical entity within the spectrum of macular disorders. "Pachychoroid" is defined as choroidal thickening associated with dilated outer choroidal vessels often showing retinal pigment epithelium (RPE) degeneration. Although various clinical studies on the pachychoroid spectrum diseases have been conducted, the pathophysiology of pachychoroid has yet to be fully elucidated. In this study, we attempted to establish a mouse model of pachychoroid. We sutured vortex veins in eyes of wild type mice to imitate the vortex vein congestion in pachychoroid spectrum diseases. Fundus photography and ultra-widefield indocyanine green angiography showed dilated vortex veins from the posterior pole to the ampulla in eyes after induction of choroidal congestion. Optical coherence tomography and tissue sections presented choroidal thickening with dilatation of choroidal vessels. The RPE-choroid/retina thickness ratios on the tissue sections in the treated day 1 and day 7 groups were significantly greater than that in the control group (0.19±0.03 and 0.16±0.01 vs. 0.12±0.02, P<0.05 each). Moreover, immunohistochemistry using RPE flatmount revealed focal RPE degeneration in the treated eyes. Furthermore, inflammatory response-related genes were upregulated in eyes with choroidal congestion induction, and macrophages migrated into the thickened choroid. These results indicated that vortex vein congestion triggered some pachychoroid features. Thus, we have established a choroidal congestion mouse model by suturing vortex veins, which would potentially be useful for investigating the pathophysiology of pachychoroid spectrum diseases.

Entities:  

Mesh:

Year:  2021        PMID: 33507997      PMCID: PMC7843010          DOI: 10.1371/journal.pone.0246115

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.240


  26 in total

1.  Pachychoroid neovasculopathy.

Authors:  Claudine E Pang; K Bailey Freund
Journal:  Retina       Date:  2015-01       Impact factor: 4.256

2.  ONE-YEAR RESULTS OF ADJUNCTIVE PHOTODYNAMIC THERAPY FOR TYPE 1 NEOVASCULARIZATION ASSOCIATED WITH THICKENED CHOROID.

Authors:  Jae Hyung Lee; Won Ki Lee
Journal:  Retina       Date:  2016-05       Impact factor: 4.256

3.  Ranibizumab versus verteporfin for neovascular age-related macular degeneration.

Authors:  David M Brown; Peter K Kaiser; Mark Michels; Gisele Soubrane; Jeffrey S Heier; Robert Y Kim; Judy P Sy; Susan Schneider
Journal:  N Engl J Med       Date:  2006-10-05       Impact factor: 91.245

4.  Ranibizumab for neovascular age-related macular degeneration.

Authors:  Philip J Rosenfeld; David M Brown; Jeffrey S Heier; David S Boyer; Peter K Kaiser; Carol Y Chung; Robert Y Kim
Journal:  N Engl J Med       Date:  2006-10-05       Impact factor: 91.245

5.  Scleral Thickness in Central Serous Chorioretinopathy.

Authors:  Naoya Imanaga; Nobuhiro Terao; Sakari Nakamine; Tamaki Tamashiro; Sorako Wakugawa; Keiko Sawaguchi; Hideki Koizumi
Journal:  Ophthalmol Retina       Date:  2020-07-16

6.  One-year outcomes of half-fluence photodynamic therapy combined with intravitreal injection of aflibercept for pachychoroid neovasculopathy without polypoidal lesions.

Authors:  Hidetaka Matsumoto; Ryo Mukai; Yuka Kikuchi; Masahiro Morimoto; Hideo Akiyama
Journal:  Jpn J Ophthalmol       Date:  2020-02-03       Impact factor: 2.447

7.  Quantification of oxygen-induced retinopathy in the mouse: a model of vessel loss, vessel regrowth and pathological angiogenesis.

Authors:  Kip M Connor; Nathan M Krah; Roberta J Dennison; Christopher M Aderman; Jing Chen; Karen I Guerin; Przemyslaw Sapieha; Andreas Stahl; Keirnan L Willett; Lois E H Smith
Journal:  Nat Protoc       Date:  2009-10-08       Impact factor: 13.491

8.  Pachychoroid pigment epitheliopathy.

Authors:  David J Warrow; Quan V Hoang; K Bailey Freund
Journal:  Retina       Date:  2013-09       Impact factor: 4.256

9.  Geographic filling delay of the choriocapillaris in the region of dilated asymmetric vortex veins in central serous chorioretinopathy.

Authors:  Shoji Kishi; Hidetaka Matsumoto; Shozo Sonoda; Takashi Hiroe; Taiji Sakamoto; Hideo Akiyama
Journal:  PLoS One       Date:  2018-11-09       Impact factor: 3.240

10.  Pachychoroid neovasculopathy and age-related macular degeneration.

Authors:  Masahiro Miyake; Sotaro Ooto; Kenji Yamashiro; Ayako Takahashi; Munemitsu Yoshikawa; Yumiko Akagi-Kurashige; Naoko Ueda-Arakawa; Akio Oishi; Hideo Nakanishi; Hiroshi Tamura; Akitaka Tsujikawa; Nagahisa Yoshimura
Journal:  Sci Rep       Date:  2015-11-06       Impact factor: 4.379

View more
  4 in total

Review 1.  Pathophysiology of central serous chorioretinopathy: a literature review with quality assessment.

Authors:  Pushpinder Kanda; Arnav Gupta; Chloe Gottlieb; Rustum Karanjia; Stuart G Coupland; Manpartap Singh Bal
Journal:  Eye (Lond)       Date:  2021-10-15       Impact factor: 4.456

2.  Subretinal fluid accumulation in a patient with polycythemia vera after receiving a prostaglandin I2 analogue treatment.

Authors:  Tomoko Noda; Kousuke Noda; Kiriko Hirooka; Satoru Kase; Susumu Ishida
Journal:  Am J Ophthalmol Case Rep       Date:  2022-05-04

3.  Vortex vein congestion in the monkey eye: A possible animal model of pachychoroid.

Authors:  Hidetaka Matsumoto; Ryo Mukai; Kazuma Saito; Junki Hoshino; Shoji Kishi; Hideo Akiyama
Journal:  PLoS One       Date:  2022-09-01       Impact factor: 3.752

4.  Pulsation of anastomotic vortex veins in pachychoroid spectrum diseases.

Authors:  Hidetaka Matsumoto; Junki Hoshino; Ryo Mukai; Kosuke Nakamura; Shoji Kishi; Hideo Akiyama
Journal:  Sci Rep       Date:  2021-07-22       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.